Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,500 shares at $63.82 ($347K) on 2018-09-10, disclosed to the SEC on 2018-09-11.
Scheduled sale ($347k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.66 | 3,637 | $228K | 65.7% |
| 2 | $63.82 | 1,863 | $119K | 34.3% |
| Total | $63.05 avg | 5,500 | $347K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |